You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Chemistry
ECLiPS Compound Collection
ECLiPS technology combines synthesis and screening technology to identify hits, drive lead optimization, and nominate development candidates. Experienced medicinal and computational chemists designed this collection to maximize the probability of lead compound generation.
FAQ
-
ECLiPS is a diverse, high-quality collection of 5.5 million small molecules designed for use in ultra high-throughput screening (uHTS) campaigns.
-
The ECLiPS collection can provide not only hit series as a starting point for your program, it can also provide positive and negative SAR after screening.
-
Yes, we offer custom screening services using the ECLiPS collection or a combination of commercial libraries and ECLiPS.
Learn more about